BioLargo Revenue, Profits - BLGO Quarterly Income Statement

Add to My Stocks
$0.27 $0.02 (8%) BLGO stock closing price Aug 16, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking BioLargo stock price alone is not sufficient. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2018 Q1 impacts the BLGO stock. Investors typically check year over year or quarter over quarter revenue growth. The BioLargo profit and loss statement for 2018 Q1 shows a net profit of $-2.32M. Profits for last year was $-2.3M. Apart from this an investor should also check BioLargo assets and BioLargo free cash flow.

View and download details of revenue and profits for BioLargo for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
BioLargo Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
BioLargo Gross Profit
Research & Development Expense----------
Selling General & Admin Expense1.16M1.1M1.11M1.16M1.05M-----
Income Before Depreciation Depletion Amortization-1.59M-1.5M-1.49M-1.45M-1.42M-1.2M-1.22M-1.23M-1.27M-0.92M
Depreciation Depletion Amortization----------
Non Operating Income--0.27M-----0.17M---
Interest Expense---1.11M-1.17M1.08M---
BioLargo Pretax Income
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-2.32M-2.3M-2.16M-2.34M-2M-2.24M-2.41M-1.61M-0.78M-1.25M
Extraordinary Items & Discontinued Operations----------
BioLargo Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS104.7M98.94M100.75M97.77M94.45M90.9M88.15M86.42M82.97M85.66M
Average Shares used to compute Basic EPS104.7M98.94M100.75M97.77M94.45M90.9M88.15M86.42M82.97M85.66M
Income Before Nonrecurring Items-2.32M-2.3M-2.16M-2.34M-2M-2.24M-2.41M-1.61M-0.78M-1.25M
Income from Nonrecurring Items----------
BioLargo Earnings Per Share Basic Net
BioLargo Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.02-0.02-0.02-0.03-0.02-0.02-0.03-0.02-0.01-0.01
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on BioLargo stock analysis. An investor must check the following items in an income statement:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: BioLargo revenue chart, implies that the company is growing. It has not been the case with BioLargo. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-2.32M for BLGO stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the BLGO income statement, one can check the BioLargo historical stock prices to check how the price has moved with time.

BioLargo Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield